MedTrace Logo

Rare Kidney Stone Consortium Patient Registry

NCT00588562 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 730

Last updated 2025-07-04

No results posted yet for this study

Summary

The purpose of this study is to collect medical information from a large number of patients in many areas of the world with primary hyperoxaluria (PH), Dent disease, Cystinuria and APRT deficiency. This information will create a registry that will help us to compare similarities and differences in patients and their symptoms. The more patients we are able to enter into the registry, the more we will be able to understand the Primary Hyperoxalurias,Dent disease, cystinuria and APRT and learn better ways of caring for patients with these diseases.

Conditions

  • Primary Hyperoxaluria
  • Dent Disease
  • Cystinuria
  • APRT Deficiency

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Oxalosis and Hyperoxaluria Foundation (OHF)

    collaborator OTHER

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Dawn S. Milliner, M.D. · Primary Hyperoxaluria Registry - Mayo Clinic, Rochester, MN

  • David Goldfarb, MD · Cystinuria Registry, New York University, NY

  • John C Lieske, MD · Dent Disease Registry, Mayo Clinic, Rochester, MN

  • Vidar Edvardsson, MD · APRT Registry, Landspitali University Hospital, Iceland

Eligibility

Min Age
0 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-07-31
Primary Completion
2028-06-30
Completion
2028-06-30

Countries

  • United States
  • Iceland

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00588562 on ClinicalTrials.gov